UBS Group Has Lowered Expectations for Aflac (NYSE:AFL) Stock Price

11 Apr 2026, 04:49 by Jessica Moore · The Cerbat Gem

Aflac (NYSE:AFL – Get Free Report) had its price target reduced by UBS Group from $116.00 to $114.00 in a report released on Thursday, Marketbeat reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. UBS Group’s target price would suggest a potential upside of 2.87% from the company’s previous close.

Other research analysts have also issued research reports about the stock. Morgan Stanley set a $120.00 price target on shares of Aflac in a research note on Monday, December 15th. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Piper Sandler raised shares of Aflac to a “strong-buy” rating in a research note on Thursday, April 2nd. Wall Street Zen downgraded Aflac from a “hold” rating to a “sell” rating in a research note on Saturday, February 28th. Finally, Mizuho set a $107.00 price target on Aflac in a research note on Monday, February 9th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Aflac has a consensus rating of “Hold” and a consensus target price of $112.27.

Read Our Latest Research Report on AFL

Aflac Price Performance

AFL opened at $110.82 on Thursday. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.29. Aflac has a 12 month low of $96.95 and a 12 month high of $119.32. The company has a fifty day simple moving average of $111.44 and a 200 day simple moving average of $110.51. The stock has a market cap of $57.09 billion, a P/E ratio of 16.11, a P/E/G ratio of 3.69 and a beta of 0.66.

Aflac (NYSE:AFL – Get Free Report) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The company had revenue of $4.28 billion for the quarter, compared to analyst estimates of $4.45 billion. During the same quarter last year, the business posted $1.57 earnings per share. The business’s quarterly revenue was down 9.6% on a year-over-year basis. On average, research analysts expect that Aflac will post 6.88 EPS for the current year.

Insider Activity

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 166,000 shares of Aflac stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $112.38, for a total value of $18,655,080.00. Following the sale, the insider owned 51,723,100 shares of the company’s stock, valued at $5,812,641,978. This trade represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 486,477 shares of company stock valued at $53,758,442. Company insiders own 0.80% of the company’s stock.

Institutional Trading of Aflac

Several hedge funds and other institutional investors have recently modified their holdings of the company. Stephens Inc. AR grew its holdings in shares of Aflac by 0.4% in the 4th quarter. Stephens Inc. AR now owns 21,945 shares of the financial services provider’s stock valued at $2,420,000 after acquiring an additional 91 shares in the last quarter. Root Financial Partners LLC grew its holdings in shares of Aflac by 4.5% in the 4th quarter. Root Financial Partners LLC now owns 2,119 shares of the financial services provider’s stock valued at $234,000 after acquiring an additional 92 shares in the last quarter. CENTRAL TRUST Co grew its holdings in shares of Aflac by 0.5% in the 4th quarter. CENTRAL TRUST Co now owns 19,088 shares of the financial services provider’s stock valued at $2,105,000 after acquiring an additional 95 shares in the last quarter. HBK Sorce Advisory LLC grew its holdings in shares of Aflac by 1.2% in the 4th quarter. HBK Sorce Advisory LLC now owns 7,702 shares of the financial services provider’s stock valued at $902,000 after acquiring an additional 95 shares in the last quarter. Finally, Confluence Wealth Services Inc. grew its holdings in shares of Aflac by 0.8% in the 4th quarter. Confluence Wealth Services Inc. now owns 11,923 shares of the financial services provider’s stock valued at $1,315,000 after acquiring an additional 96 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Key Aflac News

Here are the key news stories impacting Aflac this week:

Positive Sentiment: Evercore upgraded AFL from “strong sell” to “strong buy” — a bullish broker action that can attract buyers and support the stock. Zacks Coverage of Evercore Upgrade
Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $115 and kept a “market perform” rating—small incremental upside from current levels that may steady sentiment. Benzinga on KBW PT Raise
Neutral Sentiment: Wells Fargo trimmed its target to $116 but kept an “equal weight” view — a mild model update rather than a clear buy/sell signal. Benzinga on Wells Fargo PT Change
Neutral Sentiment: Market/valuation discussion and pre‑earnings writeups (Yahoo Finance piece) are highlighting Aflac’s multi‑year run vs. mixed valuation signals — useful context but not an immediate catalyst. Yahoo Finance Valuation Article
Neutral Sentiment: Small Q1 lobbying disclosure ($62k) was reported — routine regulatory transparency, unlikely to move fundamentals. Quiver Quant Lobbying Update
Negative Sentiment: UBS cut its price target to $114 and moved to a Neutral rating — a downgrade that likely pressured sentiment and contributed to selling. AmericanBankingNews on UBS PT Cut
Negative Sentiment: Post Holdings Co., Ltd. Japan (a >10% holder) has executed a string of disclosed share sales under a Rule 10b5‑1 plan (multiple blocks at ~\$109–\$112). The cadence of these sales, while planned and small versus its total stake, is weighing on market sentiment. SEC Filing (Post Holdings Sales)

Aflac Company Profile

(Get Free Report)

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.